Name
OÜ STROOMI PEREARSTID
Registry code
10907132
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
20.11.2002 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anne Toompuu 25.10.1969 (54) | 100% - 2 556.00 EUR | Board member | - | Founder |
| 2019 10.11.2020 | 2020 31.10.2021 | 2021 30.12.2022 | 2022 30.12.2023 | |
|---|---|---|---|---|
| Total Revenue | 264 790 € | 294 985 € | 302 369 € | 367 910 € |
| Net profit (loss) for the period | 51 980 € | 61 050 € | 56 316 € | 62 585 € |
| Profit Margin | 20% | 21% | 19% | 17% |
| Current Assets | 253 104 € | 296 541 € | 275 800 € | 315 376 € |
| Fixed Assets | 3 502 € | 2 627 € | 3 577 € | 4 781 € |
| Total Assets | 256 606 € | 299 168 € | 279 377 € | 320 157 € |
| Current Liabilities | 51 011 € | 67 523 € | 31 416 € | 49 612 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 205 595 € | 231 645 € | 247 961 € | 270 545 € |
| Employees | 6 | 6 | 6 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 32 461.01 € | 26 937.24 € | 8 |
| 2023 Q4 | - | 13 359.97 € | 13 941.17 € | 8 |
| 2023 Q3 | - | 24 915.1 € | 25 964.68 € | 7 |
| 2023 Q2 | - | 8 985.78 € | 9 380.35 € | 6 |
| 2023 Q1 | - | 23 995.51 € | 17 662.35 € | 6 |
| 2022 Q4 | - | 24 438.41 € | 25 571.46 € | 6 |
| 2022 Q3 | - | 9 585.14 € | 10 091.34 € | 6 |
| 2022 Q2 | - | 10 691.74 € | 11 217.26 € | 6 |
| 2022 Q1 | - | 20 633.86 € | 13 594.05 € | 7 |
| 2021 Q4 | - | 14 284.9 € | 14 991.48 € | 4 |
| 2021 Q3 | - | 34 038.98 € | 28 265.87 € | 4 |
| 2021 Q2 | - | 2 362.69 € | 2 540.47 € | 4 |
| 2021 Q1 | - | 14 514.48 € | 15 467.52 € | 4 |
| 2020 Q4 | - | 6 140.06 € | 6 289.82 € | 4 |
| 2020 Q3 | - | 20 378.79 € | 14 858.66 € | 4 |
| 2020 Q2 | - | 11 176.82 € | 11 915.78 € | 4 |
| 2020 Q1 | - | 27 214.47 € | 28 954.44 € | 4 |
